References
-
Alexoff DL, Casati R, Fowler JS, Wolf AP, Shea C, Schlyer DJ, et al. Ion Chromatographic Analysis of High Specific Activity
$^{18}$ FDG Preparations and Detection of the Chemical Impurity 2-Deoxy-2-chloro-D-glucose. Appl Radiat Isot 1992;43:1313-22 https://doi.org/10.1016/0883-2889(92)90002-V -
Alexoff DL, Fowler JS, Gatley SJ. Removal of the 2.2.2 Cryptand (Kryptofix 2.2.2) from
$^{18}$ FDG by Cation Exchange. Appl Radiat Isot 1989;42:1189-93 -
Chaly T, Dahl JR. Thin layer Chromatographic Detection of Kryrtofix 2.2.2 in the Routine Synthesis of [
$^{18}$ F]2-Fluoro-2-deoxy- Dglucose. Nucl Med Biol 1989;16:385-7 -
Ferrieri RA, Schlyer DJ, Alexoff DL, Fowler JS, Wolf AP, Direct Analysis of Kryptofix 2.2.2 in
$^{18}$ FDG by Gas Chromatography Using a Nitrogen-selective Detector. Nucl Med Biol 1993;20:367-9 https://doi.org/10.1016/0969-8051(93)90061-X -
Mock BH, Winkle W, Vavrek MT. A Color Spot Test for the Detection of Kryptofix 2.2.2 in [
$^{18}$ F]FDG Preparations. Nucl Med Biol 1997;24:193-5 https://doi.org/10.1016/S0969-8051(96)00212-0 -
Moerlein SM, Brodack JW, Siegel BA, Welch MJ. Elimination of Contaminant Kryptofix 2.2.2 in the Routine Production of 2-[
$^{18}$ F]Fluoro-2-deoxy-D-glucose. Appl Radiat Isot 1989;40:741-3 https://doi.org/10.1016/0883-2889(89)90090-7 -
Channing MA, Huang BX, Eckelman WC. Analysis of residual solvents in 2-[
$^{18}$ F]FDG by GC. Nucl Med Biol 2001;28:469-71 https://doi.org/10.1016/S0969-8051(00)00213-4 -
Hung JC. Comparison of Various requirements of the Quality Assurance procedures for
$^{18}$ F-FDG Injection. J Nucl Med. 2002;43: 1495-1506 -
Yu S. Review of
$^{18}$ F-FDG synthesis and Quality control. Biomed Imaging Interv J 2006;2(4):e57 - Rockville, MD. Organic volatile impurities. (2000)The United States Pharmacopeia 24/National Formulary 19 The United States Pharmacopeial Convention
-
Hamacher K, Coenen HH, Stcklin G. Efficient Stereospecific Synthesis of No-Carrier-Added 2-[
$^{18}$ F]-Fluoro-2-Deoxy-D-Glucose Using Aminopolyether supported Nucleophilic Substitution, J Nucl Med 1986;27:235-8 - Chang IL, Diubaldo D, Sanders WJ. Headspace Analysis of Organic Volatile Impurities in Bulk Pharmaceutical Chemicals. Hewlett-Packard Company, USA, 1994 Application Note 228-55
- Classification of residual solvents by risk assessment. In: Guidance for Industry: Q3C Impurities-Residual Solvents. Rockville, MD: Food and Drug Administration; 1997:3 Available at: http://www.Fda.gov/cder/guidance/Q3Cfnl.pdf. Accessed August 14, 2002
- The Merck Index 13th edition, An Encyclopedia of Chemicals, Drugs. And Biologicals. Maryadele J. O'Neil et al (Ed.). Whitehouse Station. Nj. Merck & Co., Inc. 2001
- Acetonitrile [material safety data sheet]. Thermo Fisher Scientific Inc. available USA at: http://fscimage.fishersci.com/msds/00170.html. Accessed June 19, 2007
- Ethanol SDA1, Anhydrous [material safety data sheet]. Thermo Fisher Scientific Inc. USA. available at: http://fscimage.fishersci.com/msds/88067.html. Accessed June 19, 2007